SKBI Share Price

Open 0.10 Change Price %
High 0.10 1 Day 0.02 25.00
Low 0.10 1 Week 0.02 25.00
Close 0.10 1 Month 0.02 25.00
Volume 1000 1 Year -0.10 -50.00
52 Week High 0.32
52 Week Low 0.00
SKBI Important Levels
Resistance 2 0.10
Resistance 1 0.10
Pivot 0.10
Support 1 0.10
Support 2 0.10
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
WRES 0.09 28.57%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI)

SKBI Technical Analysis 4
As on 22nd Feb 2017 SKBI Share Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.21 & Sell for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
SKBI Target for February
1st Target up-side 0.14
2nd Target up-side 0.19
3rd Target up-side 0.24
1st Target down-side -0
2nd Target down-side -0.05
3rd Target down-side -0.1
SKBI Other Details
Segment EQ
Market Capital 14449120.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.skystarbio-pharmaceutical.com
SKBI Address
SKBI
Building B
4th Floor
Xi,
China
Phone: 86 29 8819 3188
SKBI Latest News
Interactive Technical Analysis Chart Skystar Bio-Pharmaceutical Company ( SKBI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Skystar Bio-Pharmaceutical Company
SKBI Business Profile
Skystar Bio-Pharmaceutical Company (Skystar) is a holding company. The Company is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. It has four product lines: micro-organism products line, which include over 16 products; veterinary medicine line for poultry and livestock, which includes over 245 products; feed additives line, which includes over 16 products, and bio-pharmaceutical veterinary vaccine line, which includes over 10 products. All of the Company�s operations are carried out by Xi�an Tianxing Bio-Pharmaceutical Co., Limited (Xi�an Tianxing), a People�s Republic of China (PRC) joint stock company that the Company controls through contractual arrangements originally between Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (Skystar Cayman) and Xi�an Tianxing. As of December 31, 2011, it had over 3,846 customers in 29 provinces in China.